Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Miida

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 20, 2012
Small dense LDL: An emerging risk factor for cardiovascular diseaseSatoshi Hirayama, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 18, 2013
[Medical safety in infectious disease--chairmen's introductory remarks]Naoto Shimetani, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[LDL-cholesterol homogeneous assays versus Friedewald's equation]Takashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Etiology of Secondary Hyperlipidemia and Abnormalities of Lipid Laboratory Tests -Chairmen's Introductory Remarks -]Hiroshi Yoshida, Takashi Miida
Clinical Laboratory|May 10, 2016
Impact of Clotting Condition on the Measurement of Circulating MicroRNAs in SerumKazunari Hayashi, Yoko Tabe, Takashi Miida
Pharmacology & Therapeutics|November 23, 2006
Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effectsTakashi Miida, Akihiro Takahashi, Takeshi Ikeuchi
Journal of Atherosclerosis and Thrombosis|November 24, 2004
Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementiaTakashi Miida, Satoshi Hirayama, Yuichi Nakamura
Current Opinion in Lipidology|November 9, 2005
Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression?Takashi Miida, Akihiro Takahashi, Naohito Tanabe, et al.
Journal of Atherosclerosis and Thrombosis|August 24, 2025
Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for AtherosclerosisHuicheng Qi, Masatsune Ogura, Kazuko Matsuda, et al.
Annals of Clinical Biochemistry|February 13, 2015
The bromocresol green assay, but not the modified bromocresol purple assay, overestimates the serum albumin concentration in nephrotic syndrome through reaction with α2-macroglobulinTsuyoshi Ueno, Satoshi Hirayama, Masami Sugihara, et al.
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 20, 2012
Small dense LDL: An emerging risk factor for cardiovascular diseaseSatoshi Hirayama, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 18, 2013
[Medical safety in infectious disease--chairmen's introductory remarks]Naoto Shimetani, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[LDL-cholesterol homogeneous assays versus Friedewald's equation]Takashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Etiology of Secondary Hyperlipidemia and Abnormalities of Lipid Laboratory Tests -Chairmen's Introductory Remarks -]Hiroshi Yoshida, Takashi Miida
Clinical Laboratory|May 10, 2016
Impact of Clotting Condition on the Measurement of Circulating MicroRNAs in SerumKazunari Hayashi, Yoko Tabe, Takashi Miida
Pharmacology & Therapeutics|November 23, 2006
Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effectsTakashi Miida, Akihiro Takahashi, Takeshi Ikeuchi
Journal of Atherosclerosis and Thrombosis|November 24, 2004
Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementiaTakashi Miida, Satoshi Hirayama, Yuichi Nakamura
Current Opinion in Lipidology|November 9, 2005
Can statin therapy really reduce the risk of Alzheimer's disease and slow its progression?Takashi Miida, Akihiro Takahashi, Naohito Tanabe, et al.
Journal of Atherosclerosis and Thrombosis|August 24, 2025
Enhancement of ABCA1 and ABCG1 Expression and Cholesterol Efflux by a Metabolite of Tipelukast: A Potential Therapeutic Strategy for AtherosclerosisHuicheng Qi, Masatsune Ogura, Kazuko Matsuda, et al.
Annals of Clinical Biochemistry|February 13, 2015
The bromocresol green assay, but not the modified bromocresol purple assay, overestimates the serum albumin concentration in nephrotic syndrome through reaction with α2-macroglobulinTsuyoshi Ueno, Satoshi Hirayama, Masami Sugihara, et al.
Pageof 19